Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Elicio Therapeutics Inc
(NQ:
ELTX
)
4.340
-0.120 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Elicio Therapeutics Inc
< Previous
1
2
Next >
ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q2 2024
August 13, 2024
ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?
June 28, 2024
Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid tumors.
Via
Benzinga
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
June 28, 2024
Elicio Therapeutics stock is down on Friday after the company announced a proposed public offering for shares of ELTX this morning.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!
Via
InvestorPlace
Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors
June 10, 2024
Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors
Via
News Direct
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P
February 01, 2024
--News Direct--
Via
News Direct
12 Health Care Stocks Moving In Thursday's Intraday Session
May 16, 2024
Via
Benzinga
ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024
May 15, 2024
ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
April 11, 2024
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
Via
News Direct
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Unlocking the Power of Immunotherapy: Elicio Therapeutics’ (NASDAQ: ELTX) Novel AMP Platform
April 05, 2024
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
ELTX Stock Earnings: Elicio Therapeutics Misses EPS for Q4 2023
April 02, 2024
ELTX stock results show that Elicio Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Benzinga's 2024 Virtual Healthcare: What's Next In Health?
March 19, 2024
The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 07, 2024
Via
Benzinga
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
February 06, 2024
--News Direct--
Via
News Direct
Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
February 05, 2024
A clinical-stage biotechnology company has published promising preclinical data in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR).
Via
Benzinga
First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P
January 31, 2024
A phase 2 trial by a clinical-stage biotechnology company is kicking into full gear.
Via
Benzinga
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
January 30, 2024
--News Direct--
Via
News Direct
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002
January 29, 2024
Colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) are the second and
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 12, 2024
A look at five stocks seeing increased attention from investors.
Via
Benzinga
Unity Layoffs 2024: What to Know About the Latest U Job Cuts
January 09, 2024
Unity layoffs are on the way as the video game software company reveals plans to cut 1,800 jobs to focus on its core business.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?
January 09, 2024
Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.
Via
InvestorPlace
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.